These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16264064

  • 21. Coexistence of mucous membrane pemphigoid and connective-tissue disease.
    Malik M, Gürcan HM, Ahmed AR.
    Clin Exp Dermatol; 2010 Mar; 35(2):156-9. PubMed ID: 19438545
    [Abstract] [Full Text] [Related]

  • 22. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy.
    Kumari S, Bhol KC, Rehman F, Foster CS, Ahmed AR.
    Cytokine; 2001 May 21; 14(4):218-24. PubMed ID: 11448121
    [Abstract] [Full Text] [Related]

  • 23. Intravenous immunoglobulin treatment in laryngeal pemphigoid.
    Gürcan HM, Ahmed AR.
    Clin Exp Dermatol; 2009 Dec 21; 34(8):884-6. PubMed ID: 19094130
    [Abstract] [Full Text] [Related]

  • 24. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
    Tsai CP, Wang KC, Liu CY, Sheng WY, Lee TC.
    J Clin Neurosci; 2007 Jul 21; 14(7):625-9. PubMed ID: 17532498
    [Abstract] [Full Text] [Related]

  • 25. Recent advances in mucous membrane pemphigoid.
    Daniel E, Thorne JE.
    Curr Opin Ophthalmol; 2008 Jul 21; 19(4):292-7. PubMed ID: 18545009
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
    Ahmed AR, Colón JE.
    Arch Dermatol; 2001 Sep 21; 137(9):1181-9. PubMed ID: 11559214
    [Abstract] [Full Text] [Related]

  • 28. Long term safety of IVIg therapy in multiple sclerosis: 10 years experience.
    Katz U, Kishner I, Magalashvili D, Shoenfeld Y, Achiron A.
    Autoimmunity; 2006 Sep 21; 39(6):513-7. PubMed ID: 17060031
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    Maley A, Warren M, Haberman I, Swerlick R, Kharod-Dholakia B, Feldman R.
    J Am Acad Dermatol; 2016 May 21; 74(5):835-40. PubMed ID: 26936298
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM, Viala K, Maisonobe T, Bouche P.
    Bull Acad Natl Med; 2007 Oct 21; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
    Canizares MJ, Smith DI, Conners MS, Maverick KJ, Heffernan MP.
    Arch Dermatol; 2006 Nov 21; 142(11):1457-61. PubMed ID: 17116836
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.